跳至主要内容
临床试验/ACTRN12614000654651
ACTRN12614000654651招募中4 期

Effect of dexamphetamine versus a placebo on body weight, apnoea-hypopnoea index (AHI) and changes in prescribed medications in obese adults with obstructive sleep apnoea

epean Blue Mountains LHD0 个研究点目标入组 60 人开始时间: 2014年6月23日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • Adults aged 18-70, BMI 25-60, AHI (apnoea-hypopnoea index) of at least 15.

排除标准

  • History of addiction to illicit drugs, uncontrolled hypertension >140/90, symptomatic ischaemic heart disease, significant kidney or liver disease, uncontrolled epilepsy, breastfeeding, pregnant or planning pregnancy, history of bariatric surgery, current depression or other psychiatric illness, agitated states, anxiety, motor tics, Tourette syndrome, use of some medications, current or recent treatment (past 12 months) with psychotropic medication, uncontrolled endocrine disorder, glaucoma, previous severe drug reactions, significant cardiac arrhythmia, systemic glucocorticoids or medication for weight loss (eg orlistat), family history of sudden death from cardiac causes, hypersensitivity to DEX or any components of the DEX or placebo tablet.

研究者

发起方
epean Blue Mountains LHD

相似试验